Julio Rosenstock

105PUBLICATIONS
178CO-AUTHORS
Epidemiological modellingOncology and carcinogenesis not elsewhere classifiedEpigenetics (incl. genome methylation and epigenomics)PharmacogenomicsComputing education
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (105)

|Jul 02, 2026
Potential Mediators of Efpeglenatide's Cardiovascular Benefit: An Exploratory Analysis of the AMPLITUDE-O Trial.

|Jun 24, 2026
Publisher Correction: Oral small molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial.

|Jun 15, 2026
Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Albuminuria Irrespective of Baseline HbA1c Levels: A Participant-Level Exploratory Analysis of the Randomised CONFIDENCE Trial.

|Jun 05, 2026
Oral small molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial.

|Jun 05, 2026
Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood Pressure.

|May 22, 2026
Simplified Switching to Once-Weekly Insulin Icodec Without an Initial One-Time Additional Dose Versus Once-Daily Insulin Glargine U100 in Basal Insulin-Treated Type 2 Diabetes (ONWARDS 10): A Randomised Controlled Trial.

Pageof 18

Frequent Collaborators

11 joint publications

Stefano Del Prato

10 joint publications

Vanita R Aroda

10 joint publications

Rajiv Agarwal

10 joint publications

Hiddo J L Heerspink